FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2508482929> ?p ?o ?g. }

• W2508482929 abstract "Abstract Osseous involvement is one the predominant features of patients with multiple myeloma (MM). Whole body X-ray (WBX) is the standard method for detecting skeleton abnormalities but has limited value in relapsing disease since it cannot make a distinction between old and new active skeleton lesions. Therefore changes in metabolic activity might be a more useful method to detect new skeleton lesions in MM. This can be assessed by [F-18] fluorodeoxyglucose positron emission tomography (FDG-PET) imaging. Consequently WBX and FDG-PET was studied in relapsing MM prior to treatment. In addition immunohistochemical staining on bone marrow biopsies was performed for glucose transport protein (GLUT) 3 expression, micro vessel density (MVD), and vascular endothelial growth factor (VEGF) to demonstrate whether these parameters might be predictive for the in vivo scanning results. This study included 44 patients (median age 62 yr (range 48-78)) with a median of 3.5 (range 2-12) relapses. Thus far 86% of the patients were treated with autologous stem cell transplantation in combination with bortezomib (78%) or lenalidomide (65%). New lesions on FDG-PET were more frequently demonstrated than new lesions on WBX (p=0.00001). In 78% of the patients FDG-PET demonstrated a median of 4 lesions (range 0-22) per patient with a median standard uptake value (SUV) max of 5.7 (range 0-24). In 42% of the patients new X-ray lesions (median 0 (range 0-7)) were demonstrated and these were concordant with the results of FDG-PET. In 5 % of the patients new X-ray lesions were observed without FDG-PET lesions. For the relapsing patients treatment consisted of dexamethasone in combination with bortezomib (65%) or lenalidomide (50%). CR was obtained in 27% of the patients, PR in 39% and progressive disease in 22%. Average time to next treatment (TTNT) was 11.7 months (2-43). However FDG-PET positivity was not predictive for PFS (p =0.55) and OS (p=0.40) neither if PET positivity was defined as more than 3 lesions nor if the cut off value of SUV max > 4.2 was applied. Immunohistochemical staining on bone marrow biopsies (n=20) with CD34 demonstrated a significant increased MVD of 39 ± 54 (mean ± SD, normal bone marrow MVD 3.5 ± 2.9), in particular when clusters of plasma cells were present. These enhanced MVD was associated with a significant increased expression of VEGF and GLUT-3. However MVD (p = 0.16), VEGF (p = 0.70) or GLUT-3 (p =0.70) expression were not predictive for having a positive or negative FDG-PET. In summary, our results demonstrate that FDG-PET is more informative than WBX for detecting skeleton lesions in relapsing MM patients. However, and in contrast to what was previously shown in patients with newly diagnosed MM, FDG-PET it is not predictive for treatment outcome. This might be due to heterogeneity in studied patients and treatments. Disclosures: No relevant conflicts of interest to declare." @default.
• W2508482929 created "2016-09-16" @default.
• W2508482929 creator A5000133551 @default.
• W2508482929 creator A5006472498 @default.
• W2508482929 creator A5017476580 @default.
• W2508482929 creator A5050532707 @default.
• W2508482929 creator A5083889395 @default.
• W2508482929 date "2013-11-15" @default.
• W2508482929 modified "2023-09-30" @default.
• W2508482929 title "Visibility Of Bone Lesions In Relapsed Multiple Myeloma Can Be Improved By FDG-PET Scanning" @default.
• W2508482929 doi "https://doi.org/10.1182/blood.v122.21.5323.5323" @default.
• W2508482929 hasPublicationYear "2013" @default.
• W2508482929 type Work @default.
• W2508482929 sameAs 2508482929 @default.
• W2508482929 citedByCount "0" @default.
• W2508482929 crossrefType "journal-article" @default.
• W2508482929 hasAuthorship W2508482929A5000133551 @default.
• W2508482929 hasAuthorship W2508482929A5006472498 @default.
• W2508482929 hasAuthorship W2508482929A5017476580 @default.
• W2508482929 hasAuthorship W2508482929A5050532707 @default.
• W2508482929 hasAuthorship W2508482929A5083889395 @default.
• W2508482929 hasConcept C126322002 @default.
• W2508482929 hasConcept C126838900 @default.
• W2508482929 hasConcept C142724271 @default.
• W2508482929 hasConcept C199374082 @default.
• W2508482929 hasConcept C2775842073 @default.
• W2508482929 hasConcept C2776063141 @default.
• W2508482929 hasConcept C2776364478 @default.
• W2508482929 hasConcept C2777478702 @default.
• W2508482929 hasConcept C2780007613 @default.
• W2508482929 hasConcept C2911091166 @default.
• W2508482929 hasConcept C2989005 @default.
• W2508482929 hasConcept C71924100 @default.
• W2508482929 hasConceptScore W2508482929C126322002 @default.
• W2508482929 hasConceptScore W2508482929C126838900 @default.
• W2508482929 hasConceptScore W2508482929C142724271 @default.
• W2508482929 hasConceptScore W2508482929C199374082 @default.
• W2508482929 hasConceptScore W2508482929C2775842073 @default.
• W2508482929 hasConceptScore W2508482929C2776063141 @default.
• W2508482929 hasConceptScore W2508482929C2776364478 @default.
• W2508482929 hasConceptScore W2508482929C2777478702 @default.
• W2508482929 hasConceptScore W2508482929C2780007613 @default.
• W2508482929 hasConceptScore W2508482929C2911091166 @default.
• W2508482929 hasConceptScore W2508482929C2989005 @default.
• W2508482929 hasConceptScore W2508482929C71924100 @default.
• W2508482929 hasLocation W25084829291 @default.
• W2508482929 hasOpenAccess W2508482929 @default.
• W2508482929 hasPrimaryLocation W25084829291 @default.
• W2508482929 hasRelatedWork W1702325671 @default.
• W2508482929 hasRelatedWork W2032880673 @default.
• W2508482929 hasRelatedWork W2047389368 @default.
• W2508482929 hasRelatedWork W2108476771 @default.
• W2508482929 hasRelatedWork W2118888426 @default.
• W2508482929 hasRelatedWork W2282084201 @default.
• W2508482929 hasRelatedWork W2322646132 @default.
• W2508482929 hasRelatedWork W2361858588 @default.
• W2508482929 hasRelatedWork W2382884808 @default.
• W2508482929 hasRelatedWork W2394970767 @default.
• W2508482929 hasRelatedWork W2400352091 @default.
• W2508482929 hasRelatedWork W2577692854 @default.
• W2508482929 hasRelatedWork W2577802934 @default.
• W2508482929 hasRelatedWork W2794342655 @default.
• W2508482929 hasRelatedWork W2889558367 @default.
• W2508482929 hasRelatedWork W2898830720 @default.
• W2508482929 hasRelatedWork W2900783009 @default.
• W2508482929 hasRelatedWork W3017482710 @default.
• W2508482929 hasRelatedWork W3028267696 @default.
• W2508482929 hasRelatedWork W3158325261 @default.
• W2508482929 isParatext "false" @default.
• W2508482929 isRetracted "false" @default.
• W2508482929 magId "2508482929" @default.
• W2508482929 workType "article" @default.